Published in Nat Genet on May 01, 1994
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet (2007) 1.55
Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease. Neurogenetics (2009) 1.50
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol (2008) 1.41
Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A (1995) 1.40
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Alzheimers Dement (2011) 1.35
Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ (1994) 1.31
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol (1994) 1.28
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol (2012) 1.14
Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry (1996) 1.12
Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet (1996) 1.09
Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol (2011) 1.08
Family history of Alzheimer's disease and hippocampal structure in healthy people. Am J Psychiatry (2010) 1.05
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 1.01
Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet (2005) 1.00
Chaperone signalling complexes in Alzheimer's disease. J Cell Mol Med (2009) 0.99
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol Neurobiol (1999) 0.96
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. Am J Hum Genet (1994) 0.94
C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis (2012) 0.94
Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol (2005) 0.91
Multiple etiologies for Alzheimer disease are revealed by segregation analysis. Am J Hum Genet (1994) 0.91
Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population. Oncotarget (2015) 0.91
Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry (1996) 0.91
Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer's disease. J Korean Med Sci (2008) 0.90
Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci (2014) 0.89
Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci (1996) 0.88
The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample. Am J Hum Genet (2002) 0.85
Alzheimer's disease and the family effect. Nat Genet (1994) 0.84
Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am J Hum Genet (1996) 0.83
Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychol Rev (2012) 0.83
Genetic studies in Alzheimer's disease. Dialogues Clin Neurosci (2003) 0.82
Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people. Am J Geriatr Psychiatry (2012) 0.81
Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J Med Genet (1995) 0.81
Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol (1995) 0.78
APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage. Biol Res Nurs (2008) 0.78
Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1995) 0.78
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis. Br J Clin Pharmacol (2007) 0.78
CRP gene variation affects early development of Alzheimer's disease-related plaques. J Neuroinflammation (2011) 0.78
Genetic Determinants of Survival in Patientswith Alzheimer’s Disease. J Alzheimers Dis (2015) 0.78
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease. Clin Interv Aging (2016) 0.77
Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol (1995) 0.75
Apolipoprotein E genotype does not affect age at onset in patients with chromosome 14 encoded Alzheimer's disease. J Med Genet (1996) 0.75
HSV presence in brains of individuals without dementia: the TASTY brain series. Dis Model Mech (2016) 0.75
Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study. J Epidemiol Community Health (1999) 0.75
Why should primary care physicians know about the genetics of dementia? West J Med (2001) 0.75
Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease. SAGE Open Med (2016) 0.75
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk. Front Neurol (2017) 0.75
Low apolipoprotein E epsilon4 allele frequency in the population of Catalonia (Spain) determined by PCR-RFLP and Laser fluorescent sequencer. Eur J Epidemiol (1997) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 5.61
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med (1998) 3.97
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
Jefferson fathered slave's last child. Nature (1998) 3.83
Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet (2001) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Estimating Y chromosome specific microsatellite mutation frequencies using deep rooting pedigrees. Hum Mol Genet (1997) 3.78
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Characteristics and frequency of germline mutations at microsatellite loci from the human Y chromosome, as revealed by direct observation in father/son pairs. Am J Hum Genet (2000) 3.59
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Ancestral Asian source(s) of new world Y-chromosome founder haplotypes. Am J Hum Genet (1999) 2.89
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol (1999) 2.75
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
Germline mosaicism and Duchenne muscular dystrophy mutations. Nature (1987) 2.56
A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat (2004) 2.52
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Decreased selenium levels in acute myocardial infarction. JAMA (1989) 2.36
Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology (2004) 2.35
A randomized trial of sodium intake and blood pressure in newborn infants. JAMA (1983) 2.32
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30
Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22
Conjugation deficient E. coli K12 F- mutants with heptose-less lipopolysaccharide. Mol Gen Genet (1976) 2.22
Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA (1995) 2.20
Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18
Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology (2002) 2.16
QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation (1998) 2.15
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int (2005) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology (2010) 2.14
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11